Paul R Michl

Array ( [id] => 3993890 [patent_doc_number] => 05919765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Inhibitors of factor XA' [patent_app_type] => 1 [patent_app_number] => 8/483470 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18293 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 400 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919765.pdf [firstpage_image] =>[orig_patent_app_number] => 483470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3873958 [patent_doc_number] => 05763570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Glutathione analogs and paralog panels comprising glutathione mimics' [patent_app_type] => 1 [patent_app_number] => 8/473397 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20410 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763570.pdf [firstpage_image] =>[orig_patent_app_number] => 473397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3852925 [patent_doc_number] => 05767238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Inverse solid phase synthesis' [patent_app_type] => 1 [patent_app_number] => 8/483143 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10833 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767238.pdf [firstpage_image] =>[orig_patent_app_number] => 483143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4143925 [patent_doc_number] => 06031003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Calcium receptor-active molecules' [patent_app_type] => 1 [patent_app_number] => 8/484719 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 109 [patent_no_of_words] => 76096 [patent_no_of_claims] => 145 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031003.pdf [firstpage_image] =>[orig_patent_app_number] => 484719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777197 [patent_doc_number] => 05817758 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'P-nitrobenzyl side-chain protection for solid-phase synthesis' [patent_app_type] => 1 [patent_app_number] => 8/485582 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 5356 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817758.pdf [firstpage_image] =>[orig_patent_app_number] => 485582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770128 [patent_doc_number] => 05849711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Cathepsin and methods and compositions for inhibition thereof' [patent_app_type] => 1 [patent_app_number] => 8/469362 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 20926 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849711.pdf [firstpage_image] =>[orig_patent_app_number] => 469362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3984992 [patent_doc_number] => 05861476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Peptides and compounds that bind to the IL-1 receptor' [patent_app_type] => 1 [patent_app_number] => 8/464538 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38721 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861476.pdf [firstpage_image] =>[orig_patent_app_number] => 464538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741742 [patent_doc_number] => 05786331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Peptides and compounds that bind to the IL-1 receptor' [patent_app_type] => 1 [patent_app_number] => 8/465391 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38751 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 260 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786331.pdf [firstpage_image] =>[orig_patent_app_number] => 465391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103107 [patent_doc_number] => 06100236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Method and composition for treating thrombosis' [patent_app_type] => 1 [patent_app_number] => 8/465498 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 7755 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100236.pdf [firstpage_image] =>[orig_patent_app_number] => 465498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3760835 [patent_doc_number] => 05843900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Bradykinin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/465672 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12083 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843900.pdf [firstpage_image] =>[orig_patent_app_number] => 465672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848280 [patent_doc_number] => 05719128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Factor IIa inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/458997 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7029 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719128.pdf [firstpage_image] =>[orig_patent_app_number] => 458997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640042 [patent_doc_number] => 06395873 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Method and composition for treating thrombosis' [patent_app_type] => B1 [patent_app_number] => 08/456466 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 13551 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395873.pdf [firstpage_image] =>[orig_patent_app_number] => 08456466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661448 [patent_doc_number] => 05656603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Aminopeptidase P inhibitors and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/455281 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10138 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656603.pdf [firstpage_image] =>[orig_patent_app_number] => 455281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3840692 [patent_doc_number] => 05847135 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Inhibitors of interleukin-1.beta. converting enzyme' [patent_app_type] => 1 [patent_app_number] => 8/440898 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59694 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/847/05847135.pdf [firstpage_image] =>[orig_patent_app_number] => 440898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4023476 [patent_doc_number] => 05882944 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Methods for G protein coupled receptor activity screening' [patent_app_type] => 1 [patent_app_number] => 8/447277 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9547 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882944.pdf [firstpage_image] =>[orig_patent_app_number] => 447277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1415788 [patent_doc_number] => 06521594 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Method and composition for treating thrombosis' [patent_app_type] => B1 [patent_app_number] => 08/445638 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 31 [patent_no_of_words] => 26254 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521594.pdf [firstpage_image] =>[orig_patent_app_number] => 08445638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772335 [patent_doc_number] => 05807820 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Cyclosporin compositions for topical application' [patent_app_type] => 1 [patent_app_number] => 8/446984 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5851 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807820.pdf [firstpage_image] =>[orig_patent_app_number] => 446984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3897722 [patent_doc_number] => 05750647 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Synthetic peptide analogs of NTx' [patent_app_type] => 1 [patent_app_number] => 8/446206 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4075 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750647.pdf [firstpage_image] =>[orig_patent_app_number] => 446206 [rel_patent_id] =>[rel_patent_doc_number] =>)